Senner Christopher J.
Insider CIK 1648367 · CRTX Director · EXEL EVP and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-06-11 | 2026-06-15 | 2,700 | — | $0 | 2,700 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-05-18 | 2026-05-19 | 34,901 | $50.00 | $1.75M | 952,317 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2026-05-15 | 2026-05-19 | 40,892 | $51.10 | $2.09M | 987,218 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2026-02-26 | 2026-03-02 | 52,018 | — | $0 | 1,028,110 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-17 | 2026-02-18 | 30,617 | $43.67 | $1.34M | 976,092 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2026-02-15 | 2026-02-18 | 35,870 | $43.92 | $1.58M | 1,006,709 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2026-02-13 | 2026-02-18 | 34,278 | $43.00 | $1.47M | 1,042,579 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2026-01-15 | 2026-01-16 | 149,474 | — | $0 | 1,117,316 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2026-01-15 | 2026-01-16 | 40,459 | $45.23 | $1.83M | 1,076,857 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2026-01-02 | 2026-01-21 | 21,810 | — | $0 | 21,810 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 27,000 | — | $0 | 27,000 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-05-16 | 2025-05-16 | 100,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-05-16 | 2025-05-16 | 100,000 | $18.80 | $1.88M | 1,067,842 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-05-16 | 2025-05-16 | 100,000 | $46.00 | $4.60M | 967,842 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2025-05-15 | 2025-05-16 | 41,422 | $44.65 | $1.85M | 967,842 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-03-31 | 2025-03-31 | 170,009 | — | $0 | 1,009,264 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-02-26 | 2025-02-28 | 59,648 | — | $0 | 839,255 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2025-02-24 | 2025-02-26 | 29,314 | — | $0 | 100,000 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2025-02-24 | 2025-02-26 | 29,314 | $18.80 | $551.1K | 808,921 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2025-02-24 | 2025-02-26 | 29,314 | $36.14 | $1.06M | 779,607 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2025-02-15 | 2025-02-19 | 21,591 | $35.00 | $755.7K | 779,607 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2025-01-16 | 2025-01-17 | 132,973 | — | $0 | 837,147 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2025-01-16 | 2025-01-17 | 35,949 | $37.27 | $1.34M | 801,198 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-08 | 35,274 | — | $0 | 35,274 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2024-11-15 | 2024-11-19 | 17,506 | $35.05 | $613.6K | 704,174 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2024-08-09 | 2024-08-09 | 125,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2024-08-09 | 2024-08-09 | 125,000 | $27.19 | $3.40M | 721,680 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2024-08-09 | 2024-08-09 | 125,000 | $24.41 | $3.05M | 846,680 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 27,000 | — | $0 | 27,000 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2024-05-15 | 2024-05-17 | 11,478 | $20.99 | $240.9K | 721,680 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2024-05-15 | 2024-05-17 | 10,211 | $20.99 | $214.3K | 733,158 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2024-05-15 | 2024-05-17 | 8,621 | $20.99 | $181.0K | 743,369 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-02-23 | 2024-02-27 | 82,121 | — | $0 | 751,990 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2024-01-11 | 2024-01-16 | 80,186 | — | $0 | 691,731 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2024-01-11 | 2024-01-16 | 21,862 | $22.86 | $499.8K | 669,869 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2023-09-06 | 2023-09-08 | 17,147 | $22.27 | $381.9K | 611,545 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2023-09-06 | 2023-09-08 | 65,135 | — | $0 | 628,692 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2023-08-15 | 2023-08-17 | 8,074 | $21.51 | $173.7K | 563,557 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2023-08-04 | 2023-08-07 | 60,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2023-08-04 | 2023-08-07 | 60,000 | $20.68 | $1.24M | 571,631 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2023-08-04 | 2023-08-07 | 60,000 | $14.74 | $884.4K | 631,631 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2023-08-03 | 2023-08-07 | 60,000 | — | $0 | 60,000 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2023-08-03 | 2023-08-07 | 60,000 | $14.74 | $884.4K | 631,631 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2023-08-03 | 2023-08-07 | 60,000 | $20.51 | $1.23M | 571,631 | SEC↗ |
| QNCX Quince Therapeutics, Inc. | A Award deriv | 2023-05-24 | 2023-05-26 | 27,000 | — | $0 | 27,000 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2023-05-15 | 2023-05-17 | 10,002 | $19.18 | $191.8K | 571,631 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2023-05-15 | 2023-05-17 | 8,444 | $19.18 | $162.0K | 581,633 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2023-04-03 | 2023-04-05 | 85,414 | — | $0 | 590,077 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2023-02-15 | 2023-02-17 | 5,278 | $18.08 | $95.4K | 504,663 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-11-15 | 2022-11-17 | 8,074 | $16.71 | $134.9K | 509,941 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2022-08-11 | 2022-08-12 | 225,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-08-11 | 2022-08-12 | 152,867 | $19.23 | $2.94M | 518,015 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2022-08-11 | 2022-08-12 | 225,000 | $6.21 | $1.40M | 670,882 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2022-08-03 | 2022-08-05 | 32,567 | — | $0 | 453,956 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-08-03 | 2022-08-05 | 8,074 | $21.49 | $173.5K | 445,882 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 27,000 | — | $0 | 27,000 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-05-15 | 2022-05-17 | 8,444 | $20.08 | $169.6K | 421,389 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2022-03-04 | 2022-03-08 | 75,985 | — | $0 | 429,833 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-02-15 | 2022-02-17 | 15,626 | $18.59 | $290.5K | 353,848 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2022-02-15 | 2022-02-17 | 2,701 | $18.59 | $50.2K | 369,474 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-12-15 | 2021-12-17 | 5,131 | $17.00 | $87.2K | 372,175 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-12-15 | 2021-12-17 | 19,491 | — | $0 | 377,306 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-11-15 | 2021-11-17 | 2,566 | $18.10 | $46.4K | 404,735 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-11-15 | 2021-11-17 | 46,920 | $18.10 | $849.3K | 357,815 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-11-15 | 2021-11-17 | 8,227 | $18.10 | $148.9K | 407,301 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-09-30 | 2021-10-04 | 32,567 | — | $0 | 424,101 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-09-30 | 2021-10-04 | 8,573 | $20.63 | $176.9K | 415,528 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2021-09-21 | 2021-09-23 | 90,000 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2021-09-21 | 2021-09-23 | 90,000 | $3.66 | $329.4K | 446,591 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-09-21 | 2021-09-23 | 55,057 | $20.33 | $1.12M | 391,534 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2021-06-16 | 2021-06-17 | 11,029 | — | $0 | 11,029 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-03-04 | 2021-03-05 | 64,150 | — | $0 | 356,591 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-02-15 | 2021-02-17 | 4,105 | $21.91 | $89.9K | 292,441 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2021-02-03 | 2021-02-05 | 18,206 | $22.56 | $410.7K | 296,546 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-02-03 | 2021-02-05 | 59,411 | — | $0 | 314,752 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2021-02-03 | 2021-02-05 | 9,745 | — | $0 | 255,341 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2021-01-12 | 2021-01-14 | 30,000 | — | $0 | 90,000 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2021-01-12 | 2021-01-14 | 30,000 | $25.00 | $750.0K | 245,596 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2021-01-12 | 2021-01-14 | 30,000 | $3.66 | $109.8K | 275,596 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2020-11-15 | 2020-11-17 | 8,227 | $20.16 | $165.9K | 248,229 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2020-11-15 | 2020-11-17 | 2,633 | $20.16 | $53.1K | 245,596 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2020-11-15 | 2020-11-17 | 2,737 | $20.16 | $55.2K | 256,456 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2020-10-22 | 2020-10-26 | 46,920 | $21.79 | $1.02M | 259,193 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2020-10-22 | 2020-10-26 | 178,231 | — | $0 | 306,113 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-10-08 | 2020-10-09 | 10,000 | — | $0 | 120,000 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-10-08 | 2020-10-09 | 10,000 | $25.00 | $250.0K | 127,882 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-10-08 | 2020-10-09 | 10,000 | $3.66 | $36.6K | 137,882 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-09-15 | 2020-09-15 | 20,000 | — | $0 | 130,000 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-09-15 | 2020-09-15 | 20,000 | $25.00 | $500.0K | 127,882 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-09-15 | 2020-09-15 | 20,000 | $3.66 | $73.2K | 147,882 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2020-09-02 | 2020-09-04 | 9,745 | — | $0 | 130,448 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2020-09-02 | 2020-09-04 | 2,566 | $21.58 | $55.4K | 127,882 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-06-08 | 2020-06-09 | 11,029 | — | $0 | 11,029 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-05-08 | 2020-05-08 | 78,583 | — | $0 | 150,000 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-05-08 | 2020-05-08 | 78,583 | $25.81 | $2.03M | 120,703 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-05-08 | 2020-05-08 | 78,583 | $3.66 | $287.6K | 199,286 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2020-05-07 | 2020-05-08 | 21,417 | — | $0 | 228,583 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2020-05-07 | 2020-05-08 | 21,417 | $3.66 | $78.4K | 142,120 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2020-05-07 | 2020-05-08 | 21,417 | $25.80 | $552.6K | 120,703 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2019-12-04 | 2019-12-06 | 15,592 | — | $0 | 124,793 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2019-12-04 | 2019-12-06 | 4,090 | $17.67 | $72.3K | 120,703 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2019-11-15 | 2019-11-15 | 8,196 | $16.51 | $135.3K | 111,824 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2019-11-15 | 2019-11-15 | 2,623 | $16.51 | $43.3K | 109,201 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2019-09-12 | 2019-09-13 | 2,737 | $19.26 | $52.7K | 120,020 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2019-09-12 | 2019-09-13 | 10,395 | — | $0 | 122,757 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2019-05-03 | 2019-05-03 | 36,261 | $20.70 | $750.6K | 112,362 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2018-11-30 | 2018-11-30 | 8,791 | $19.70 | $173.2K | 146,950 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2018-11-15 | 2018-11-16 | 5,882 | $17.45 | $102.6K | 157,623 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2018-11-15 | 2018-11-16 | 1,882 | $17.45 | $32.8K | 155,741 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2018-09-10 | 2018-09-12 | 129,314 | — | $0 | 129,314 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2017-11-15 | 2017-11-17 | 2,762 | $24.75 | $68.4K | 162,497 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2017-10-03 | 2017-10-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2017-10-03 | 2017-10-05 | 62,500 | — | $0 | 165,259 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2017-09-12 | 2017-09-14 | 100,000 | — | $0 | 250,000 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2017-09-12 | 2017-09-14 | 100,000 | $3.66 | $366.0K | 202,759 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2017-09-12 | 2017-09-14 | 100,000 | $26.79 | $2.68M | 102,759 | SEC↗ |
| EXEL EXELIXIS, INC. | S Sale | 2017-03-03 | 2017-03-03 | 11,000 | $22.80 | $250.8K | 100,398 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2016-09-22 | 2016-11-23 | 120,000 | — | $0 | 120,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-09-22 | 2016-11-23 | 20,000 | — | $0 | 125,976 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2016-09-22 | 2016-09-26 | 120,000 | — | $0 | 120,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-09-22 | 2016-09-26 | 20,000 | — | $0 | 152,727 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2016-07-15 | 2016-11-23 | 46,751 | $8.44 | $394.6K | 105,976 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2016-02-11 | 2016-02-16 | 20,845 | $4.20 | $87.5K | 132,727 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2016-02-11 | 2016-02-16 | 53,572 | — | $0 | 153,572 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2015-09-16 | 2015-09-18 | 225,000 | — | $0 | 225,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2015-07-15 | 2015-07-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award | 2015-07-15 | 2015-07-17 | 100,000 | — | $0 | 100,000 | SEC↗ |